AI-generated summary
The authors reviewed published English-language studies on preventing and treating medication-related osteonecrosis of the jaw, a side effect of certain bone-acting drugs. They report that pentoxifylline with alpha tocopherol, teriparatide, photobiomodulation, photodynamic therapy and growth factors were associated with better healing and new bone formation. The authors note that larger studies and controlled trials are needed to confirm these findings.
- Who or what was studied
- Patients with medication-related osteonecrosis of the jaw receiving antiresorptive or antiangiogenic agents
- Limits stated in the abstract
- The authors state that the findings require further validation through larger studies and controlled trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Photobiomodulation, Wound healing. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.